Fetzima on Blue Cross MedicareRx Basic (S5715-014)
levomilnacipran hydrochloride
Covered.
Tier 4 (non-preferred drug). Quantity limit of 30 per 30 days.
$236.21
Patient pays / month, after deductible
$562.41
Patient pays / month, before the $615.00 deductible
$708.64
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
FETZIMA 80 mg Capsule, Extended Release at a preferred retail pharmacy, from the plan's negotiated price of $562.41 for a month. Other covered strengths are listed below.
All 5 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| FETZIMA 120 mg Capsule, Extended Release | 4 | $236.73 | 30 per 30 days |
| FETZIMA 20 mg Capsule, Extended Release | 4 | $241.48 | 30 per 30 days |
| FETZIMA 40 mg Capsule, Extended Release | 4 | $240.48 | 30 per 30 days |
| FETZIMA 80 mg Capsule, Extended Release | 4 | $236.21 | 30 per 30 days |
| FETZIMA Kit | 4 | $252.89 | 28 per 28 days |
Verify with the plan before prescribing or filling. Member services: (888)285-2249. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5715-014